Pathway-selective insulin resistance and metabolic disease: The importance of nutrient flux

Journal of Biological Chemistry

Volumn 289, Issue 30, 2014, Pages 20462-20469

  Otero, Yolanda F ^a   Stafford, John M ^b,c   McGuinness, Owen P ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; NUTRIENTS; PHYSIOLOGY; SIGNALING;

DIFFERENTIAL REGULATION; GLUCOSE METABOLISM; HEPATIC STEATOSIS; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; INSULIN SIGNALING; METABOLIC DISEASE; METABOLIC SYNDROMES;

METABOLISM;

GLUCOSE; INSULIN;

ANIMAL; FATTY LIVER; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPOGENESIS; LIVER; METABOLIC SYNDROME X; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; DIABETES MELLITUS, TYPE 2; FATTY LIVER; GLUCOSE; HUMANS; HYPERTRIGLYCERIDEMIA; INSULIN; INSULIN RESISTANCE; LIPOGENESIS; LIVER; METABOLIC SYNDROME X; SIGNAL TRANSDUCTION;

EID: 84905381985     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.R114.576355     Document Type: Review

References (104)

1. Carey, M., Kehlenbrink, S., and Hawkins, M. (2013) Evidence for central regulation of glucose metabolism. J. Biol. Chem. 288, 34981-34988
2. Brown, M. S., and Goldstein, J. L. (2008) Selective versus total insulin resistance: a pathogenic paradox. Cell Metab. 7, 95-96
3. King, G. L., and Brownlee, M. (1996) The cellular and molecular mechanisms of diabetic complications. Endocrinol. Metab. Clin. North Am. 25, 255-270
4. Jiang, Z. Y., Lin, Y. W., Clemont, A., Feener, E. P., Hein, K. D., Igarashi, M., Yamauchi, T., White, M. F., and King, G. L. (1999) Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J. Clin. Invest. 104, 447-457
5. Cryer, P. E. (2012) Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes. Endocrinology 153, 1039-1048
6. Basu, A., Shah, P., Nielsen, M., Basu, R., and Rizza, R. A. (2004) Effects of type 2 diabetes on the regulation of hepatic glucose metabolism. J. Investig. Med. 52, 366-374
7. Rizza, R. A. (2010) Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy. Diabetes 59, 2697-2707
8. Basu, R., Chandramouli, V., Dicke, B., Landau, B., and Rizza, R. (2005) Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis. Diabetes 54, 1942-1948
9. Bock, G., Chittilapilly, E., Basu, R., Toffolo, G., Cobelli, C., Chandramouli, V., Landau, B. R., and Rizza, R. A. (2007) Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis. Diabetes 56, 1703-1711
10. Pagliassotti, M. J., and Cherrington, A. D. (1992) Regulation of net hepatic glucose uptake in vivo. Annu. Rev. Physiol. 54, 847-860
11. Moore, M. C., Cherrington, A. D., and Wasserman, D. H. (2003) Regulation of hepatic and peripheral glucose disposal. Best Pract. Res. Clin. Endocrinol. Metab. 17, 343-364
12. Shah, P., Vella, A., Basu, A., Basu, R., Adkins, A., Schwenk, W. F., Johnson, C. M., Nair, K. S., Jensen, M. D., and Rizza, R. A. (2002) Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans. Diabetes 51, 301-310
13. Shah, P., Vella, A., Basu, A., Basu, R., Adkins, A., Schwenk, W. F., Johnson, C. M., Nair, K. S., Jensen, M. D., and Rizza, R. A. (2003) Elevated free fatty acids impair glucose metabolism in women: decreased stimulation of muscle glucose uptake and suppression of splanchnic glucose production during combined hyperinsulinemia and hyperglycemia. Diabetes 52, 38-42
14. Anderka, O., Boyken, J., Aschenbach, U., Batzer, A., Boscheinen, O., and Schmoll, D. (2008) Biophysical characterization of the interaction between hepatic glucokinase and its regulatory protein: impact of physiological and pharmacological effectors. J. Biol. Chem. 283, 31333-31340
15. McGuinness, O. P., and Cherrington, A. D. (2003) Effects of fructose on hepatic glucose metabolism. Curr. Opin. Clin. Nutr. Metab. Care 6, 441-448
16. Van Schaftingen, E., Detheux, M., and Veiga da Cunha, M. (1994) Shortterm control of glucokinase activity: a role of a regulatory protein. FASEB J. 8, 414-419
17. Jetton, T. L., Liang, Y., Pettepher, C. C., Zimmerman, E. C., Cox, F. G., Horvath, K., Matschinsky, F. M., and Magnuson, M. A. (1994) Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut. J. Biol. Chem. 269, 3641-3654
18. Postic, C., Shiota, M., Niswender, K. D., Jetton, T. L., Chen, Y., Moates, J. M., Shelton, K. D., Lindner, J., Cherrington, A. D., and Magnuson, M. A. (1999) Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic β cell-specific gene knock-outs using Cre recombinase. J. Biol. Chem. 274, 305-315
19. Torres, T. P., Fujimoto, Y., Donahue, E. P., Printz, R. L., Houseknecht, K. L., Treadway, J. L., and Shiota, M. (2011) Defective glycogenesis contributes toward the inability to suppress hepatic glucose production in response to hyperglycemia and hyperinsulinemia in Zucker diabetic fatty rats. Diabetes 60, 2225-2233
20. Torres, T. P., Catlin, R. L., Chan, R., Fujimoto, Y., Sasaki, N., Printz, R. L., Newgard, C. B., and Shiota, M. (2009) Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in Zucker diabetic fatty rats. Diabetes 58, 78-86
21. Fujimoto, Y., Torres, T. P., Donahue, E. P., and Shiota, M. (2006) Glucose toxicity is responsible for the development of impaired regulation of endogenous glucose production and hepatic glucokinase in Zucker diabetic fatty rats. Diabetes 55, 2479-2490
22. Nordlie, R. C., and Foster, J. D. (2010) A retrospective review of the roles of multifunctional glucose-6-phosphatase in blood glucose homeostasis: genesis of the tuning/retuning hypothesis. Life Sci. 87, 339-349
23. Froissart, R., Piraud, M., Boudjemline, A. M., Vianey-Saban, C., Petit, F., Hubert-Buron, A., Eberschweiler, P. T., Gajdos, V., and Labrune, P. (2011) Glucose-6-phosphatase deficiency. Orphanet. J. Rare Dis. 6, 27
24. Clore, J. N., Stillman, J., and Sugerman, H. (2000) Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes. Diabetes 49, 969-974
25. Hornbuckle, L. A., Everett, C. A., Martin, C. C., Gustavson, S. S., Svitek, C. A., Oeser, J. K., Neal, D. W., Cherrington, A. D., and O'Brien, R. M. (2004) Selective stimulation of G-6-Pase catalytic subunit but not G-6-P transporter gene expression by glucagon in vivo and cAMP in situ. Am. J Physiol. Endocrinol. Metab. 286, E795-E808
26. Samuel, V. T., Beddow, S. A., Iwasaki, T., Zhang, X. M., Chu, X., Still, C. D., Gerhard, G. S., and Shulman, G. I. (2009) Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with type 2 diabetes. Proc. Natl. Acad. Sci. U. S. A. 106, 12121-12126
27. Roach, P. J., Depaoli-Roach, A. A., Hurley, T. D., and Tagliabracci, V. S. (2012) Glycogen and its metabolism: some new developments and old themes. Biochem. J. 441, 763-787
28. Moore, M. C., Cherrington, A. D., Cline, G., Pagliassotti, M. J., Jones, E. M., Neal, D. W., Badet, C., and Shulman, G. I. (1991) Sources of carbon for hepatic glycogen synthesis in the conscious dog. J. Clin. Invest. 88, 578-587
29. Giaccari, A., and Rossetti, L. (1992) Predominant role of gluconeogenesis in the hepatic glycogen repletion of diabetic rats. J. Clin. Invest. 89, 36-45
30. Chueh, F. Y., Malabanan, C., and McGuinness, O. P. (2006) Impact of portal glucose delivery on glucose metabolism in conscious, unrestrained mice. Am. J. Physiol. Endocrinol. Metab. 291, E1206-E1211
31. Ros, S., Zafra, D., Valles-Ortega, J., García-Rocha, M., Forrow, S., Domínguez, J., Calbó, J., and Guinovart, J. J. (2010) Hepatic overexpression of a constitutively active form of liver glycogen synthase improves glucose homeostasis. J. Biol. Chem. 285, 37170-37177
32. Ros, S., García-Rocha, M., Calbó, J., and Guinovart, J. (2011) Restoration of hepatic glycogen deposition reduces hyperglycaemia, hyperphagia and gluconeogenic enzymes in a streptozotocin-induced model of diabetes in rats. Diabetologia 54, 2639-2648
33. Jeong, J. Y., Jeoung, N. H., Park, K. G., and Lee, I. K. (2012) Transcriptional regulation of pyruvate dehydrogenase kinase. Diabetes Metab. J. 36, 328-335
34. Tao, R., Xiong, X., Harris, R. A., White, M. F., and Dong, X. C. (2013) Genetic inactivation of pyruvate dehydrogenase kinases improves hepatic insulin resistance induced diabetes. PLoS ONE 8, e71997
35. Lewis, G. F. (1997) Fatty acid regulation of very low density lipoprotein production. Curr. Opin. Lipidol. 8, 146-153
36. Chong, M. F. F., Fielding, B. A., and Frayn, K. N. (2007) Metabolic interaction of dietary sugars and plasma lipids with a focus on mechanisms and de novo lipogenesis. Proc. Nutr. Soc. 66, 52-59
37. Prahl, A., Guptill, L., Glickman, N. W., Tetrick, M., and Glickman, L. T. (2007) Time trends and risk factors for diabetes mellitus in cats presented to veterinary teaching hospitals. J. Feline Med. Surg. 9, 351-358
38. O'Brien, T. D. (2002) Pathogenesis of feline diabetes mellitus. Mol. Cell. Endocrinol. 197, 213-219
39. Irimia, J. M., Meyer, C. M., Peper, C. L., Zhai, L., Bock, C. B., Previs, S. F., McGuinness, O. P., DePaoli-Roach, A., and Roach, P. J. (2010) Impaired glucose tolerance and predisposition to the fasted state in liver glycogen synthase knock-out mice. J. Biol. Chem. 285, 12851-12861
40. Bandsma, R. H., Prinsen, B. H., van der Velden Mde, S., Rake, J. P., Boer, T., Smit, G. P., Reijngoud, D. J., and Kuipers, F. (2008) Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a. Pediatr. Res. 63, 702-707
41. Edgerton, D. S., Ramnanan, C. J., Grueter, C. A., Johnson, K. M. S., Lautz, M., Neal, D. W., Williams, P. E., and Cherrington, A. D. (2009) Effects of insulin on the metabolic control of hepatic gluconeogenesis in vivo. Diabetes 58, 2766-2775
42. Ramnanan, C. J., Edgerton, D. S., Rivera, N., Irimia-Dominguez, J., Farmer, B., Neal, D. W., Lautz, M., Donahue, E. P., Meyer, C. M., Roach, P. J., and Cherrington, A. D. (2010) Molecular characterization of insulinmediated suppression of hepatic glucose production in vivo. Diabetes 59, 1302-1311
43. Burgess, S. C., He, T., Yan, Z., Lindner, J., Sherry, A. D., Malloy, C. R., Browning, J. D., and Magnuson, M. A. (2007) Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver. Cell Metab. 5, 313-320
44. Catchpole, B., Kennedy, L. J., Davison, L. J., and Ollier, W. E. R. (2008) Canine diabetes mellitus: from phenotype to genotype. J. Small Anim. Pract. 49, 4-10
45. Jungas, R. L., Halperin, M. L., and Brosnan, J. T. (1992) Quantitative analysis of amino acid oxidation and related gluconeogenesis in humans. Physiol. Rev. 72, 419-448
46. Grundy, S. M. (2000) Metabolic complications of obesity. Endocrine 13, 155-165
47. Grundy, S. M., Mok, H. Y., Zech, L., Steinberg, D., and Berman, M. (1979) Transport of very low density lipoprotein triglycerides in varying degrees of obesity and hypertriglyceridemia. J. Clin. Invest. 63, 1274-1283
48. Fabbrini, E., Mohammed, B. S., Magkos, F., Korenblat, K. M., Patterson, B. W., and Klein, S. (2008) Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 134, 424-431
49. Barrows, B. R., and Parks, E. J. (2006) Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. J. Clin. Endocrinol. Metab. 91, 1446-1452
50. Lambert, J. E., and Parks, E. J. (2012) Postprandial metabolism of meal triglyceride in humans. Biochim. Biophys. Acta 1821, 721-726
51. Timlin, M. T., Barrows, B. R., and Parks, E. J. (2005) Increased dietary substrate delivery alters hepatic fatty acid recycling in healthy men. Diabetes 54, 2694-2701
52. Stanhope, K. L., Bremer, A. A., Medici, V., Nakajima, K., Ito, Y., Nakano, T., Chen, G., Fong, T. H., Lee, V., Menorca, R. I., Keim, N. L., and Havel, P. J. (2011) Consumption of fructose and high fructose corn syrup increase postprandial triglycerides, LDL-cholesterol, and apolipoprotein-B in young men and women. J. Clin. Endocrinol. Metab. 96, E1596-E1605
53. Vedala, A., Wang, W., Neese, R. A., Christiansen, M. P., and Hellerstein, M. K. (2006) Delayed secretory pathway contributions to VLDL-triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans. J. Lipid Res. 47, 2562-2574
54. Strable, M. S., and Ntambi, J. M. (2010) Genetic control of de novo lipogenesis: role in diet-induced obesity. Crit. Rev. Biochem. Mol. Biol. 45, 199-214
55. 2O quantification. Am. J. Physiol. Endocrinol. Metab. 302, E209-E217
56. Hellerstein, M. K. (1999) De novo lipogenesis in humans: metabolic and regulatory aspects. Eur. J Clin. Nutr. 53, Suppl. 1, S53-S65
57. Beysen, C., Murphy, E. J., Nagaraja, H., Decaris, M., Riiff, T., Fong, A., Hellerstein, M. K., and Boyle, P. J. (2008) A pilot study of the effects of pioglitazone and rosiglitazone on de novo lipogenesis in type 2 diabetes. J. Lipid Res. 49, 2657-2663
58. Beaven, S. W., Matveyenko, A., Wroblewski, K., Chao, L., Wilpitz, D., Hsu, T. W., Lentz, J., Drew, B., Hevener, A. L., and Tontonoz, P. (2013) Reciprocal regulation of hepatic and adipose lipogenesis by liverXreceptors in obesity and insulin resistance. Cell Metab. 18, 106-117
59. Shimomura, I., Bashmakov, Y., Ikemoto, S., Horton, J. D., Brown, M. S., and Goldstein, J. L. (1999) Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. U. S. A. 96, 13656-13661
60. -/- mutant mice are protected against fatty liver under high-fat, high-carbohydrate dietary and de novo lipogenic conditions. J. Biol. Chem. 287, 12578-12588
61. Abu-Elheiga, L., Oh, W., Kordari, P., and Wakil, S. J. (2003) Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets. Proc. Natl. Acad. Sci. U. S. A. 100, 10207-10212
62. Olson, D. P., Pulinilkunnil, T., Cline, G. W., Shulman, G. I., and Lowell, B. B. (2010) Gene knockout of Acc2 has little effect on body weight, fat mass, or food intake. Proc. Natl. Acad. Sci. U. S. A. 107, 7598-7603
63. Erion, D. M., Popov, V., Hsiao, J. J., Vatner, D., Mitchell, K., Yonemitsu, S., Nagai, Y., Kahn, M., Gillum, M. P., Dong, J., Murray, S. F., Manchem, V. P., Bhanot, S., Cline, G. W., Shulman, G. I., and Samuel, V. T. (2013) The role of the carbohydrate response element-binding protein in male fructose-fed rats. Endocrinology 154, 36-44
64. Dentin, R., Benhamed, F., Hainault, I., Fauveau, V., Foufelle, F., Dyck, J. R., Girard, J., and Postic, C. (2006) Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes 55, 2159-2170
65. Eissing, L., Scherer, T., Tödter, K., Knippschild, U., Greve, J. W., Buurman, W. A., Pinnschmidt, H. O., Rensen, S. S., Wolf, A. M., Bartelt, A., Heeren, J., Buettner, C., and Scheja, L. (2013) De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health. Nat. Commun. 4, 1528
66. Stansbie, D., Brownsey, R. W., Crettaz, M., and Denton, R. M. (1976) Acute effects in vivo of anti-insulin serum on rates of fatty acid synthesis and activities of acetyl-coenzyme A carboxylase and pyruvate dehydrogenase in liver and epididymal adipose tissue of fed rats. Biochem. J. 160, 413-416
67. Otero, Y. F., Lundblad, T. M., Ford, E. A., House, L. M., and McGuinness, O. P. (2014) Liver but not adipose tissue is responsive to the pattern of enteral feeding. Physiol. Rep. 2, e00250
68. Cryer, P. E. (2010) Hypoglycemia in type 1 diabetes mellitus. Endocrinol. Metab. Clin. North Am. 39, 641-654
69. Jornayvaz, F. R., Birkenfeld, A. L., Jurczak, M. J., Kanda, S., Guigni, B. A., Jiang, D. C., Zhang, D., Lee, H.-Y., Samuel, V. T., and Shulman, G. I. (2011) Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2. Proc. Natl. Acad. Sci. U. S. A. 108, 5748-5752
70. Monetti, M., Levin, M. C., Watt, M. J., Sajan, M. P., Marmor, S., Hubbard, B. K., Stevens, R. D., Bain, J. R., Newgard, C. B., Farese, R. V., Sr., Hevener, A. L., and Farese, R. V., Jr. (2007) Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab. 6, 69-78
71. Choi, C. S., Savage, D. B., Kulkarni, A., Yu, X. X., Liu, Z. X., Morino, K., Kim, S., Distefano, A., Samuel, V. T., Neschen, S., Zhang, D., Wang, A., Zhang, X. M., Kahn, M., Cline, G. W., Pandey, S. K., Geisler, J. G., Bhanot, S., Monia, B. P., and Shulman, G. I. (2007) Suppression of diacylglycerol acyltransferase-2(DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance. J. Biol. Chem. 282, 22678-22688
72. Cao, J., Zhou, Y., Peng, H., Huang, X., Stahler, S., Suri, V., Qadri, A., Gareski, T., Jones, J., Hahm, S., Perreault, M., McKew, J., Shi, M., Xu, X., Tobin, J. F., and Gimeno, R. E. (2011) Targeting acyl-CoA: diacylglycerol acyltransferase 1 (DGAT1) with small molecule inhibitors for the treatment of metabolic diseases. J. Biol. Chem. 286, 41838-41851
73. Banarer, S., and Cryer, P. E. (2004) Hypoglycemia in type 2 diabetes. Med. Clin. North Am. 88, 1107-1116
74. Sparks, J. D., Sparks, C. E., and Adeli, K. (2012) Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia. Arterioscler. Thromb. Vasc. Biol. 32, 2104-2112
75. Wu, K., Cappel, D., Martinez, M., and Stafford, J. M. (2010) Impairedinactivation of FoxO1 contributes to glucose-mediated increases in serum very low-density lipoprotein. Endocrinology 151, 3566-3576
76. Kamagate, A., Qu, S., Perdomo, G., Su, D., Kim, D. H., Slusher, S., Meseck, M., and Dong, H. H. (2008) FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. J. Clin. Invest. 118, 2347-2364
77. Chen, Z., Newberry, E. P., Norris, J. Y., Xie, Y., Luo, J., Kennedy, S. M., and Davidson, N. O. (2008) ApoB100 is required for increased VLDL-triglyceride secretion by microsomal triglyceride transfer protein in ob/ob mice. J. Lipid Res. 49, 2013-2022
78. Rizzo, M., and Wierzbicki, A. S. (2011) New lipid modulating drugs: the role of microsomal transport protein inhibitors. Curr. Pharm. Des. 17, 943-949
79. Sidossis, L. S., Mittendorfer, B., Walser, E., Chinkes, D., and Wolfe, R. R. (1998) Hyperglycemia-induced inhibition of splanchnic fatty acid oxidation increases hepatic triacylglycerol secretion. Am. J. Physiol. 275, E798-E805
80. Mittendorfer, B., Patterson, B. W., Klein, S., and Sidossis, L. S. (2003) VLDL-triglyceride kinetics during hyperglycemia-hyperinsulinemia: effects of sex and obesity. Am. J. Physiol. Endocrinol. Metab. 284, E708-E715
81. Sørensen, L. P., Søndergaard, E., Nellemann, B., Christiansen, J. S., Gormsen, L. C., and Nielsen, S. (2011) Increased VLDL-triglyceride secretion precedes impaired control of endogenous glucose production in obese, normoglycemic men. Diabetes 60, 2257-2264
82. Smith, G. I., Magkos, F., Reeds, D. N., Okunade, A. L., Patterson, B. W., and Mittendorfer, B. (2013) One day of mixed meal overfeeding reduces hepatic insulin sensitivity and increases VLDL particle but not VLDLtriglyceride secretion in overweight and obese men. J. Clin. Endocrinol. Metab. 98, 3454-3462
83. Lewis, G. F., Uffelman, K. D., Szeto, L. W., Weller, B., and Steiner, G. (1995) Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J. Clin. Invest. 95, 158-166
84. Conte, C., Fabbrini, E., Kars, M., Mittendorfer, B., Patterson, B. W., and Klein, S. (2012) Multiorgan insulin sensitivity in lean and obese subjects. Diabetes Care 35, 1316-1321
85. Basu, A., Dalla Man, C., Basu, R., Toffolo, G., Cobelli, C., and Rizza, R. A. (2009) Effects of type 2 diabetes on insulin secretion, insulin action, glucose effectiveness, and postprandial glucose metabolism. Diabetes Care 32, 866-872
86. Miles, J. M., Wooldridge, D., Grellner, W. J., Windsor, S., Isley, W. L., Klein, S., and Harris, W. S. (2003) Nocturnal and postprandial free fatty acid kinetics in normal and type 2 diabetic subjects: effects of insulin sensitization therapy. Diabetes 52, 675-681
87. Bandsma, R. H. J., Wiegman, C. H., Herling, A. W., Burger, H.-J., ter Harmsel, A., Meijer, A. J., Romijn, J. A., Reijngoud, D.-J., and Kuipers, F. (2001) Acute inhibition of glucose-6-phosphate translocator activity leads to increased de novo lipogenesis and development of hepatic steatosis without affecting VLDL production in rats. Diabetes 50, 2591-2597
88. Mutel, E., Abdul-Wahed, A., Ramamonjisoa, N., Stefanutti, A., Houberdon, I., Cavassila, S., Pilleul, F., Beuf, O., Gautier-Stein, A., Penhoat, A., Mithieux, G., and Rajas, F. (2011) Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas. J. Hepatol. 54, 529-537
89. Semple, R. K., Sleigh, A., Murgatroyd, P. R., Adams, C. A., Bluck, L., Jackson, S., Vottero, A., Kanabar, D., Charlton-Menys, V., Durrington, P., Soos, M. A., Carpenter, T. A., Lomas, D. J., Cochran, E. K., Gorden, P., O'Rahilly, S., and Savage, D. B. (2009) Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J. Clin. Invest. 119, 315-322
90. Hudgins, L. C., Parker, T. S., Levine, D. M., and Hellerstein, M. K. (2011) A dual sugar challenge test for lipogenic sensitivity to dietary fructose. J. Clin. Endocrinol. Metab. 96, 861-868
91. Stanhope, K. L., and Havel, P. J. (2009) Fructose consumption: considerations for future research on its effects on adipose distribution, lipid metabolism, and insulin sensitivity in humans. J. Nutr. 139, 1236S-1241S
92. O'Brien, R. M., Streeper, R. S., Ayala, J. E., Stadelmaier, B. T., and Hornbuckle, L. A. (2001) Insulin-regulated gene expression. Biochem. Soc. Trans. 29, 552-558
93. Leavens, K. F., Easton, R. M., Shulman, G. I., Previs, S. F., and Birnbaum, M. J. (2009) Akt2 is required for hepatic lipid accumulation in models of insulin resistance. Cell Metab. 10, 405-418
94. Laplante, M., and Sabatini, D. M. (2010) mTORC1 activates SREBP-1c and uncouples lipogenesis from gluconeogenesis. Proc. Natl. Acad. Sci. U. S. A. 107, 3281-3282
95. Li, S., Brown, M. S., and Goldstein, J. L. (2010) Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc. Natl. Acad. Sci. U. S. A. 107, 3441-3446
96. Yuan, M., Pino, E., Wu, L., Kacergis, M., and Soukas, A. A. (2012) Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2. J. Biol. Chem. 287, 29579-29588
97. Haas, J. T., Miao, J., Chanda, D., Wang, Y., Zhao, E., Haas, M. E., Hirschey, M., Vaitheesvaran, B., Farese, R. V., Jr., Kurland, I. J., Graham, M., Crooke, R., Foufelle, F., and Biddinger, S. B. (2012) Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression. Cell Metab. 15, 873-884
98. Poupeau, A., and Postic, C. (2011) Cross-regulation of hepatic glucose metabolism via ChREBP and nuclear receptors. Biochim. Biophys. Acta 1812, 995-1006
99. Benhamed, F., Denechaud, P. D., Lemoine, M., Robichon, C., Moldes, M., Bertrand-Michel, J., Ratziu, V., Serfaty, L., Housset, C., Capeau, J., Girard, J., Guillou, H., and Postic, C. (2012) The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. J. Clin. Invest. 122, 2176-2194
100. Iizuka, K., Bruick, R. K., Liang, G., Horton, J. D., and Uyeda, K. (2004) Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. Proc. Natl. Acad. Sci. U. S. A. 101, 7281-7286
101. Chakravarthy, M. V., Pan, Z., Zhu, Y., Tordjman, K., Schneider, J. G., Coleman, T., Turk, J., and Semenkovich, C. F. (2005) "New" hepatic fat activates PPARα to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab. 1, 309-322
102. Mittendorfer, B., Patterson, B. W., and Klein, S. (2003) Effect of weight loss on VLDL-triglyceride and apoB-100 kinetics in women with abdominal obesity. Am. J. Physiol. Endocrinol. Metab. 284, E549-E556
103. Sullivan, S., Kirk, E. P., Mittendorfer, B., Patterson, B. W., and Klein, S. (2012) Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. Hepatology 55, 1738-1745
104. Zhu, L., Brown, W. C., Cai, Q., Krust, A., Chambon, P., McGuinness, O. P., and Stafford, J. M. (2013) Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance. Diabetes 62, 424-434